Journal of Current Glaucoma Practice

Register      Login

VOLUME 6 , ISSUE 2 ( May-August, 2012 ) > List of Articles

REVIEW ARTICLE

Selective Laser Trabeculoplasty: An Overview

Bhaskar Jha, Shibal Bhartiya, Reetika Sharma, Tarun Arora, Tanuj Dada

Keywords : Selective laser trabeculoplasty, Lasers in glaucoma, Argon laser trabeculoplasty, Compliance and glaucoma

Citation Information : Jha B, Bhartiya S, Sharma R, Arora T, Dada T. Selective Laser Trabeculoplasty: An Overview. J Curr Glaucoma Pract 2012; 6 (2):79-90.

DOI: 10.5005/jp-journals-10008-1111

License: CC BY-NC 4.0

Published Online: 01-08-2012

Copyright Statement:  Copyright © 2012; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Given the obvious quality of life concerns with medical and surgical lowering of intraocular pressure (IOP), lasers have received considerable attention as a therapeutic modality for glaucoma. Selective laser trabeculoplasty (SLT) is increasingly being used in clinical practice as both the primary procedure and as an adjunct to medical and surgical therapy. Preliminary published evidence suggests that SLT is an effective, compliance-free, repeatable and safe therapeutic modality having only minor, transient, self-limiting or easily controlled side effects with no sequelae. This review attempts a broad overview of the current knowledge of its mechanism, efficacy, indications and limitations, point out the knowledge lacunae that still exist with respect to this highly promising technology which has captured the attention of glaucoma surgeons all over the world.


PDF Share
  1. Sommer A, Tielsch JM, Katz J, Quigley HA, Gottsch JD, Javitt JC, Martone JF, Royall RM, Witt KA, Ezrine S. Racial differences in the cause specific prevalence of blindness in east Baltimore. N Engl J Med 1991 Nov;325(20):1412-1417.
  2. Worthen DM, Wickham MG. Argon laser trabeculotomy. Trans Am Acad Ophthalmol Otolaryngol 1974 Mar- Apr;78(2):OP371-75.
  3. Krasnov MM. Laseropuncture of anterior chamber angle in glaucoma. Am J Ophthalmol 1973 Apr;75(4):674-678.
  4. Wise JB, Witter SL. Argon laser therapy for open-angle glaucoma: A pilot study. Arch Ophthalmol 1979 Feb;97(2):319- 322.
  5. Spurny RC, Lederer CM Jr. Krypton laser trabeculoplasty. A clinical report. Arch Ophthalmol 1984 Nov;102(11):1626-1628.
  6. Belgrado, G.; Brihaye-Van, GM, Herzeel R. Comparison of argon and CW Nd: YAG laser trabeculoplasty, Clinical results. In: Marshall J, editor. Laser technology in ophthalmology. Berkeley: Amsterdam; Kugler & Ghedini; Berkeley, CA: Distributor for the USA and Canada, Kugler Publications; 1988. pp.45-52.
  7. McHugh D, Marshall J, Ffytche TJ, Hamilton PA, Raven A. Diode laser trabeculoplasty (DLT) for primary open-angle glaucoma and ocular hypertension. Br J Ophthalmol 1990 Dec;74(12):743-747.
  8. The glaucoma laser trial research group. The glaucoma laser trial (GLT). 2. Results of argon laser trabeculoplasty versus topical medicines. Ophthalmology 1990 Nov;97(11):1403-1413.
  9. The glaucoma laser trial research group. The glaucoma laser trial (GLT) and glaucoma laser trial follow-up study: 7. Results. Am J Ophthalmol 1995 Dec;120(6):718-731.
  10. Lee R, Hutnik CM. Projected cost comparison of selective laser trabeculoplasty versus glaucoma medication in the Ontario Health Insurance Plan. Can J Ophthalmol 2006 Aug;41(4): 449-456.
  11. Lee MD, Fechtner FR, Fiscella RG, Singh K, Stewart WC. Emerging perspectives on glaucoma: Highlights of a roundtable discussion. Am J Ophthalmol 2000 Oct;130(4 Suppl):S1-S11.
  12. Nordstrom BL, Friedman DS, Mozaffari E, Quigley HA, Walker AM. Persistence and adherence with topical glaucoma therapy. Am J Ophthalmol 2005 Oct;140(4):598-606.
  13. Olthoff CM, Schouten JS, van de Borne BW, Webers CA. Noncompliance with ocular hypotensive treatment in patients with glaucoma or ocular hypertension an evidence-based review. Ophthalmology 2005 Jun;112(6):953-961.
  14. Stewart WC, Konstas AG, Pfeiffer N. Patient and ophthalmologist attitudes concerning compliance and dosing in glaucoma treatment. J Ocul Pharmacol Ther 2004 Dec;20(6):461-469.
  15. Nelson WL, Fraunfelder FT, Sills JM, Arrowsmith JB, Kuritsky JN. Adverse respiratory and cardiovascular events attributed to timolol ophthalmic solution, 1978-1985. Am J Ophthalmol 1986 Nov;102(5):606-611.
  16. Osborne SA, Montgomery DM, Morris D, McKay IC. Alphagan allergy may increase the propensity for multiple eye-drop allergy. Eye (Lond) 2005 Feb;19(2):129-137.
  17. Noecker RJ, Herrygers LA, Anwaruddin R. Corneal and conjunctival changes caused by commonly used glaucoma medications. Cornea 2004 Jul;23(5):490-496.
  18. Broadway DC, Grierson I, O'Brien C, Hitchings RA. Adverse effects of topical antiglaucoma medication. The conjunctival cell profile. Arch Ophthalmol 1994 Nov;112:1437-45.
  19. Broadway DC, Grierson I, O'Brien C, Hitchings RA. Adverse effects of topical antiglaucoma medication. II. The outcome of filtration surgery. Arch Ophthalmol 1994;112(11):1446-1454.
  20. Chiba T, Kashiwagi K, Ishijima K, Furuichi M, Kogure S, Abe K, Chiba N, Tsukahara S. A prospective study of iridial pigmentation and eyelash changes due to ophthalmic treatment with latanoprost. Jpn J Ophthalmol 2004 Mar- Apr;48(2):141-147.
  21. Anderson RR, Parish JA. Selective photothermolysis: Precise microsurgery by selective absorption of pulsed radiation. Science 1983 Apr;220(4596):524-527.
  22. van der Zypen E, Fankhauser F, England C, Kwasniewska S. Morphology of the trabecular meshwork within monkey (Macaca speciosa) eyes after irradiation with the free-running Nd: YAG laser. Ophthalmology 1987 Feb;94(2):171-179.
  23. Latina MA, Park C. Selective targeting of trabecular meshwork cells: In vitro studies of pulsed and CW laser interactions. Exp Eye Res 1995 Apr;60(4):359-371.
  24. Rodriguez MM, Spaeth GL, Donohoo P. Electron microscopy of argon laser therapy in phakik open angle glaucoma. Ophthalmology 1982 Mar;89(3):198-210.
  25. Anderson RR, Margolis RJ, Watenabe S, Flotte T, Hruza GJ, Dover JS. Selective photothermolysis of cutaneous pigmentation by Q-switched Nd:YAG laser pulses at 1064, 532, and 355 nm. J Invest Dermatol 1989 Jul;93(1):28-32.
  26. Parrish JA, Deustch TF. Laser photomedicine. IEEE J Quantum Electron 1984;12:1386-1396.
  27. Mchugh D, Marshall J, Ffytche TJ, Hamilton PA, Raven A. Ultrastructural changes of human trabecular meshwork after photocoagulation with a diode laser. Invest Ophthalmol Vis Sci 1992 Aug;33(9):2664-2671.
  28. Lin CP, Kelly MW, Sibayan SA, Latina MA. Selective cell killing by microparticle absorption of pulsed laser radiation. IEEE J Select Topics Quant Electron 1999 Jul-Aug;5(4):963-968.
  29. Sherwood KA, Murray S, Kurban AK, Tan OT. Effect of wavelength on cutaneous pigment using pulsed irradiation. J Invest Dermatol 1989 May;92(5):717-720.
  30. Van Buskirk EM. Pathophysiology of laser trabeculoplasty. Surv Ophthalmol 1989 Jan-Feb;33(4):264-272.
  31. Byslma SS, Samples JR, Acott TS, Van Buskirk EM. Trabecular cell division following argon laser trabeculoplasty. Arch Ophthalmol 1988 Apr;106(4):544-547.
  32. Byslma SS, Samples JR, Acott TS, Van Buskirk EM. Repopulation of the trabecular meshwork after argon laser trabeculoplasty. Invest Ophthalmol Vis Sci 1988;29 (Suppl):129.
  33. Gard TL, Acott TS, Van Buskirk EM. Proteoglycans and flow resistance in model of the trabecular meshwork. Invest Ophthalmol Vis Sci 1987;28(Suppl):130.
  34. Knepper PA, Farbman AI, Telser AG. Aqueous outflow pathway glycosaminoglycans. Exp Eye Res 1981 Mar;32(3):265-277.
  35. Van Buskirk EM, Pond V, Rosenquist RC, Acott TS. Argon laser trabeculoplasty studies of mechanism of action. Ophthalmology 1984 Sep;91(9):1005-1010.
  36. Melamed S, Pei J, Epstein DL. Short-term effect of argon laser trabeculoplasty in monkeys. Arch Ophthalmol 1985 Oct;103(10):1546-1552.
  37. Gracner T, Naji M, Hudovernik M, Gracner B, Pahor D. Predictive factors of successful selective laser trabeculoplasty in open-angle glaucoma. Klin Monbl Augenheilkd 2007 Dec; 224(12):922-926. (Ger).
  38. Hodge WG, Damji KF, Rock W, Buhrmann R, Bovell AM, Pan Y. Baseline IOP predicts selective laser trabeculoplasty success at 1 year Posttreatment: Results from a randomized clinical trial. Br J Ophthalmol 2005 Sep;89(9):1157-1160.
  39. Mao AJ, Pan XJ, McIlraith I, Strasfeld M, Colev G, Hutnik C. Development of a prediction rule to estimate the probability of acceptable intraocular pressure reduction after selective laser trabeculoplasty in open-angle glaucoma and ocular hypertension. J Glaucoma 2008 Sep;17(6):449-454.
  40. Ayala M, Chen E. Predictive factors of success in selective laser trabeculoplasty (SLT) treatment. Clin Ophthalmol 2011;5:573- 576.
  41. Latina MA, Sibayan SA, Shin DH, Noecker RJ, Marcellino G. Q-switched 532-nm Nd:YAG laser trabeculoplasty (selective laser trabeculoplasty): A multicenter, pilot, clinical study. Ophthalmology 1998 Nov;105(11):2082-2090.
  42. Lanzetta P, Menchini U, Virgili G. Immediate intraocular pressure response to selective laser trabeculoplasty. Br J Ophthalmol 1999 Jan;83(1):29-32.
  43. Chen E, Golchin S, Blomdahl S. A comparison between 90 degrees and 180 degrees selective laser trabeculoplasty. J Glaucoma 2004 Feb;13(1):62-65.
  44. Johnson PB, Katz LJ, Rhee DJ. Selective laser trabeculoplasty: Predictive value of early intraocular pressure measurements for success at 3 months. Br J Ophthalmol 2006 Jun;90(6):741-743.
  45. Cvenkel B. One-year follow-up of selective laser trabeculoplasty. In open-angle glaucoma. Ophthalmologica 2004 Jan- Feb;218(1):20-25.
  46. Gracner T. Intraocular pressure response to selective laser trabeculoplasty in the treatment of primary open-angle glaucoma. Ophthalmologica 2001 Jul-Aug;215(4):267-270.
  47. Kajiya S, Hayakawa K, Sawaguchi S. Clinical results of selective laser trabeculoplasty. Jpn J Ophthalmol 2000 Sep;44(5):574-575.
  48. Hodge WG, Damji KF, Rock W, Buhrmann R, Bovell AM, Pan Y. Baseline IOP predicts selective laser trabeculoplasty success at 1 year posttreatment: Results from a randomised clinical trial. Br J Ophthalmol 2005 Sep;89(9):1157-1160.
  49. Katz LJ, Steinmann WC, Kabir A, Molineaux J, Wizov SS, Marcellino G; SLT/Med Study Group. Selective laser trabeculoplasty versus medical therapy as initial treatment of glaucoma: A prospective, randomized trial. J Glaucoma 2012 Sep;21(7):460-468.
  50. Nagar M, Ogunyomade A, O'Brart DP, Howes F, Marshall J. A randomized prospective study comparing selective laser trabeculoplasty with latanoprost for the control of intraocular pressure in ocular hypertension and open angle glaucoma. Br J Ophthalmol 2005 Nov; 89(11):1413-1417.
  51. Lai JS, Chua JK, Tham CC, Lam DS. Five-year follow-up of selective laser trabeculoplasty in Chinese eyes. Clin Experiment Ophthalmol 2004 Aug;32(4):368-372.
  52. McIlraith I, Strasfeld M, Colev G, Hutnik CM. Selective laser trabeculoplasty as initial and adjunctive treatment for open-angle glaucoma. J Glaucoma 2006 Apr;15(2):124-130.
  53. Damji KF, Shah KC, Rock WJ, Bains HS, Hodge WG. Selective laser trabeculoplasty V Argon laser trabeculoplasty: A prospective randomised clinical trial. Br J Ophthalmol 1999 Jun;83(6):718-722.
  54. Juzych MS, Chopra V, Banitt MR, Hughes BA, Kim C, Goulas MT, Shin DH. Comparison of long-term outcomes of selective laser trabeculoplasty versus argon laser trabeculoplasty in openangle glaucoma. Ophthalmology 2004 Oct;111(10):1853-1859.
  55. Martinez-de-la-Casa JM, Garcia-Feijoo J, Castillo A, Matilla M, Macias JM, Benitez-del-Castillo JM, Garcia-Sanchez J. Selective vs argon laser trabeculoplasty: Hypotensive efficacy, anterior chamber inflammation and postoperative pain. Eye (Lond) 2004 May;18(5):498-502.
  56. Damji KF, Bovell AM, Hodge WG, Rock W, Shah K, Buhrmann R, Pan YI. Selective laser trabeculoplasty versus argon laser trabeculoplasty: Results from a 1-year randomised clinical trial. Br J Ophthalmol 2006 Dec;90(12):1490-1494.
  57. Best UP, Domack H, Schmidt V. Pressure reduction after selective laser trabeculoplasty with two different laser systems and after argon laser trabeculoplasty—a controlled prospective clinical trial on 284 eyes. Klin Monatsbl Augenheilkd 2007 Mar;224(3):173-179. (Ger).
  58. Popiela G, Muzyka M, Szelepin L, et al. Use of YAG-Selecta laser and argon laser in the treatment of open angle glaucoma. Klin Oczna 2000;102(2):129-133.
  59. Song J, Lee PP, Epstein DL, Stinnett SS, Herndon LW Jr, Asrani SG, Allingham RR, Challa P. High failure rate associated with 180 degrees selective laser trabeculoplasty. J Glaucoma 2005 Oct;14(5):400-408.
  60. Prasad N, Murthy S, Dagianis JJ, Latina MA. A comparison of the intervisit intraocular pressure fluctuation after 180 and 360 degrees of selective laser trabeculoplasty (SLT) as a primary therapy in primary open angle glaucoma and ocular hypertension. J Glaucoma 2009 Feb;18(2):157-160.
  61. Ayala M, Chen E. Long-term outcomes of selective laser trabeculoplasty (SLT) treatment. Open Ophthalmol J 2011;5:32- 34.
  62. Ho CL, Lai JS, Aquino MV, Rojanapongpun P, Wong HT, Aquino MC, Gerber Y, Belkin M, Barkana Y. Selective laser trabeculoplasty for primary angle closure with persistently elevated intraocular pressure after iridotomy. J Glaucoma 2009 Sep;18(7):563-566.
  63. Rubin B, Taglienti A, Rothman RF, Marcus CH, Serle JB. The effect of selective laser trabeculoplasty on intraocular pressure in patients with intravitreal steroid-induced elevated intraocular pressure. J Glaucoma 2008 Jun-Jul;17(4):287-292.
  64. Bozkurt E, Kara N, Yazici AT, Yuksel K, Demirok A, Yilmaz OF, Demir S. Prophylactic selective laser trabeculoplasty in the prevention of intraocular pressure elevation after intravitreal triamcinolone acetonide injection. A J Ophthalmol 2011 Dec;152(6):976-981.
  65. Pizzimenti JJ, Nickerson MM, Pizzimenti CE, Kasten-Aker AG. Selective laser trabeculoplasty for intraocular pressure elevation after intravitreal triamcinolone acetonide injection. Optom Vis Sci 2006 Jul;83(7):421-425.
  66. Gracner T. Intraocular pressure response of capsular glaucoma and primary openangle glaucoma to selective Nd: YAG laser trabeculoplasty: A prospective, comparative clinical trial. Eur J Ophthalmol 2002 Jul-Aug;12(4):287-292.
  67. Melamed S, Ben Simon GJ, Levkovitch-Verbin H. Selective laser trabeculoplasty as primary treatment for open-angle glaucoma: A prospective, nonrandomized pilot study. Arch Ophthalmol 2003 Jul;121(7):957-960.
  68. El Mallah MK, Walsh MM, Stinnett SS, Asrani SG. Selective laser trabeculoplasty reduces mean IOP and IOP variation in normal tension glaucoma patients. Clin Ophthalmol 2010 Aug;4:889-893.
  69. Van de Veire S, Zeyen T, Stalmans I. Argon versus selective laser trabeculoplasty. Bull Soc Belge Ophtalmol 2006;299:5-10.
  70. Harasymowycz PJ, Papamatheakis DG, Latina M, De Leon M, Lesk MR, Damji KF. Selective laser trabeculoplasty (SLT) complicated by intraocular pressure elevation in eyes with heavily pigmented trabecular meshworks. Am J Ophthalmol 2005 Jun;139(6):1110-1113.
  71. Hong BK, Winer JC, Martone JF, Wand M, Altman B, Shields B. Repeat selective laser trabeculoplasty. J Glaucoma 2009 Mar;18(3):180-183.
  72. Nordstrom BL, Friedman DS, Mozaffari E, Quigley HA, Walker AM. Persistence and adherence with topical glaucoma therapy. Am J Ophthalmol 2005 Oct;140(4):598-606.
  73. Cantor LB, Katz LZ, Cheng JW, Chen E, Tong KB, Peabody JW. Economic evaluation of medication, laser trabeculoplasty and filtering surgeries in treating patients with glaucoma in the US. Curr Med Res Opin 2008 Oct; 24(10):2905-2918.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.